Clinical trials
Blood Coagulation Disorders trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Swedish Orphan Biovitrum | 6 |
| BioMarin Pharmaceutical | 2 |
| Genzyme, a Sanofi Company | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Diagnostica Stago R&D | 1 |
| Institut Bergonié | 1 |
| Nantes University Hospital | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blood Coagulation Disorders | 22 |
| Coagulation Protein Disorders | 10 |
| Hematologic Diseases | 9 |
| Hemophilia A | 9 |
| Hemorrhagic Disorders | 9 |
| Genetic Diseases, Inborn | 6 |
| Blood Coagulation Disorders, Inherited | 5 |
| Hemophilia B | 5 |
| Blood Platelet Disorders | 2 |
| Bone Marrow Diseases | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.